HomeBCRX • NASDAQ
BioCryst Pharmaceuticals Inc
$5.08
After Hours:
$5.09
(0.20%)+0.010
Closed: Mar 28, 4:51:09 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$5.15
Day range
$5.06 - $5.34
Year range
$4.82 - $9.07
Market cap
1.05B USD
Avg Volume
3.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
93.40M17.42%
Operating expense
64.03M27.67%
Net income
-61.73M13.71%
Net profit margin
-66.0926.52%
Earnings per share
-0.2826.32%
EBITDA
-36.11M19.94%
Effective tax rate
2.27%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
388.99M-8.32%
Total assets
516.96M-6.01%
Total liabilities
972.49M15.14%
Total equity
-455.53M
Shares outstanding
206.15M
Price to book
-2.33
Return on assets
-18.15%
Return on capital
-22.80%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-61.73M13.71%
Cash from operations
-8.92M62.61%
Cash from investing
-28.47M-136.87%
Cash from financing
-3.17M-175.57%
Net change in cash
-40.04M-169.16%
Free cash flow
11.81M174.46%
About
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Founded
1986
Employees
536
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu